CAS 2220184-50-7

CDK12-IN-3

CAS : 2220184-50-7

CDK12-IN-3

Degré de pureté : ≥98%

Masse moléculaire : 470.52g/mol

Ref: 54-BUP12531

CDK12-IN-3

CAS : 2220184-50-7

CDK12-IN-3 is a selective inhibitor targeting Cyclin-Dependent Kinase 12 (CDK12). It is synthesized as a small molecule compound designed for research and therapeutic exploration. The action of CDK12-IN-3 involves the inhibition of CDK12, a kinase crucial for regulating transcription elongation and mRNA processing, particularly in genes with large transcription units. By inhibiting CDK12, CDK12-IN-3 affects the transcriptional program responsible for DNA damage response and repair pathways.

Formule : C₂₃H₂₈F₂N₈O

Degré de pureté : Min. 95%

Masse moléculaire : 470.5 g/mol

Ref: 3D-VND18450

CDK12-IN-3

CAS : 2220184-50-7

CDK12-IN-3 is a CDK12 inhibitor with anti-tumor activity and can be used for the study of malignant tumors.

Formule : C₂₃H₂₈F₂N₈O

Degré de pureté : 99.85%

Couleur et forme : Solid

Masse moléculaire : 470.52

Ref: TM-T14990